TY  - JOUR

T1  - Estimating the clinical effectiveness and value-based price range of erenumab for the prevention of migraine in patients with prior treatment failures: a US societal perspective

JO  - Journal of Medical Economics (JME)

UR  - https://eprints.whiterose.ac.uk/id/eprint/131770

PY  - 2018/07/03

AU  - Lipton RB

AU  - Brennan A

AU  - Palmer S

AU  - Hatswell AJ

AU  - Porter JK

AU  - Sapra S

AU  - Villa G

AU  - Shah N

AU  - Tepper S

AU  - Dodick D

ED  - 

DO  - DOI: 10.1080/13696998.2018.1457533

PB  - Taylor & Francis

VL  - 21

IS  - 7

SP  - 666

EP  - 675

Y2  - 2025/11/01

ER  -